Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

Richard W. Joseph; Jeroen Elassaiss-Schaap; Richard Kefford; Wen Jen Hwu; Jedd D. Wolchok; Anthony M. Joshua; Antoni Ribas; F. Stephen Hodi; Omid Hamid; Caroline Robert; Adil Daud; Roxana Dronca; Peter Hersey; Jeffrey S. Weber; Amita Patnaik; Dinesh P. de Alwis; Andrea Perrone; Jin Zhang; S. Peter Kang; Scot Ebbinghaus; Keaven M. Anderson; Tara C. Gangadhar

doi:10.1158/1078-0432.CCR-18-3340

Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

Richard W. Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, Wen Jen Hwu, Jedd D. Wolchok, Anthony M. Joshua, Antoni Ribas, F. Stephen Hodi, Omid Hamid, Caroline Robert, Adil Daud, Roxana Dronca, Peter Hersey, Jeffrey S. Weber, Amita Patnaik, Dinesh P. de Alwis, Andrea Perrone, Jin Zhang, S. Peter Kang, Scot EbbinghausKeaven M. Anderson, Tara C. Gangadhar

Résultats de recherche: Contribution à un journal › !!Comment/debate

12 Citations (Scopus)

Résumé

In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

langue originale	Anglais
Pages (de - à)	6098
Nombre de pages	1
journal	Clinical Cancer Research
Volume	24
Numéro de publication	23
Les DOIs	https://doi.org/10.1158/1078-0432.CCR-18-3340
état	Publié - 1 déc. 2018

Accès au document

10.1158/1078-0432.CCR-18-3340

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Stephen Hodi, F., Hamid, O., Robert, C., Daud, A., Dronca, R., Hersey, P., Weber, J. S., Patnaik, A., de Alwis, D. P., Perrone, A., Zhang, J., Peter Kang, S., ... Gangadhar, T. C. (2018). Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386). Clinical Cancer Research, 24(23), 6098. https://doi.org/10.1158/1078-0432.CCR-18-3340

@article{0eacec096d8e4e17bec07fda4b6797ae,

title = "Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)",

abstract = "In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.",

author = "Joseph, {Richard W.} and Jeroen Elassaiss-Schaap and Richard Kefford and Hwu, {Wen Jen} and Wolchok, {Jedd D.} and Joshua, {Anthony M.} and Antoni Ribas and {Stephen Hodi}, F. and Omid Hamid and Caroline Robert and Adil Daud and Roxana Dronca and Peter Hersey and Weber, {Jeffrey S.} and Amita Patnaik and {de Alwis}, {Dinesh P.} and Andrea Perrone and Jin Zhang and {Peter Kang}, S. and Scot Ebbinghaus and Anderson, {Keaven M.} and Gangadhar, {Tara C.}",

note = "Publisher Copyright: {\textcopyright} 2018 American Association for Cancer Research.",

year = "2018",

month = dec,

day = "1",

doi = "10.1158/1078-0432.CCR-18-3340",

language = "English",

volume = "24",

pages = "6098",

journal = "Clinical Cancer Research",

issn = "1078-0432",

number = "23",

}

Joseph, RW, Elassaiss-Schaap, J, Kefford, R, Hwu, WJ, Wolchok, JD, Joshua, AM, Ribas, A, Stephen Hodi, F, Hamid, O, Robert, C, Daud, A, Dronca, R, Hersey, P, Weber, JS, Patnaik, A, de Alwis, DP, Perrone, A, Zhang, J, Peter Kang, S, Ebbinghaus, S, Anderson, KM & Gangadhar, TC 2018, 'Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)', Clinical Cancer Research, VOL. 24, Numéro 23, p. 6098. https://doi.org/10.1158/1078-0432.CCR-18-3340

Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386). / Joseph, Richard W.; Elassaiss-Schaap, Jeroen; Kefford, Richard et al.
Dans: Clinical Cancer Research, Vol 24, Numéro 23, 01.12.2018, p. 6098.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Correction

T2 - Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

AU - Joseph, Richard W.

AU - Elassaiss-Schaap, Jeroen

AU - Kefford, Richard

AU - Hwu, Wen Jen

AU - Wolchok, Jedd D.

AU - Joshua, Anthony M.

AU - Ribas, Antoni

AU - Stephen Hodi, F.

AU - Hamid, Omid

AU - Robert, Caroline

AU - Daud, Adil

AU - Dronca, Roxana

AU - Hersey, Peter

AU - Weber, Jeffrey S.

AU - Patnaik, Amita

AU - de Alwis, Dinesh P.

AU - Perrone, Andrea

AU - Zhang, Jin

AU - Peter Kang, S.

AU - Ebbinghaus, Scot

AU - Anderson, Keaven M.

AU - Gangadhar, Tara C.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

AB - In the original version of this article (1), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85057789854&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-18-3340

DO - 10.1158/1078-0432.CCR-18-3340

M3 - Comment/debate

C2 - 30510087

AN - SCOPUS:85057789854

SN - 1078-0432

VL - 24

SP - 6098

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 23

ER -

Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM et al. Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386). Clinical Cancer Research. 2018 déc. 1;24(23):6098. doi: 10.1158/1078-0432.CCR-18-3340